Gabriele Bergers

1 ta ish

University of California, San Francisco

1. Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation

   Elizabeth Allen, Arnaud Jabouille, Lee B. Rivera +8

   MaqolaOAOchiq kirish20172 iqtibos

   ABIABI:AkademIndex/2026.other.132173